Management of cystic prolactinomas: a review

ConclusionsRecent studies suggest that dopamine agonist therapy may be an effective and safe treatment option in a considerable portion of patients with cystic prolactinomas. We suggest that dopamine agonists should be considered as a first-line therapy for cystic prolactinoma in the absence of indications for early surgical intervention.

Source: Pituitary - April 13, 2018 Category: Endocrinology Source Type: research